Skip to main content

Table 1 Characteristic of the survey population by group

From: Family physician and endocrinologist coordination as the basis for diabetes care in clinical practice

  Group A Group B
N (Men/Women) 57 (43/14) 59 (39/20)
Age (yr.) 69 (58–74) 70 (57–76)
Duration of disease (yr) 19 (10–26) 19 (10–28)
Diabetes complications n (%)   
Diabetic retinopathy 35 (61) 33 (56)
Diabetic neuropathy 44 (77) 47 (80)
Diabetic nephropathy 26 (46) 33 (56)
Diabetes Treatment n (%)   
Oral agents 18 (32) 20 (34)
Insulin 41 (72) 37 (63)
Lipid lowering Treatment n (%)   
Statins 44 (77) 35 (59)
Fibrates 2 (4) 7 (12)
Antihypertensive treatment n (%)   
ACE inhibitors or ARA II 51 (88) 46 (78)
3 or more drugs 7 (12) 11 (19)
Antiaggregation n (%) 50 (88) 53 (90)
Actual smokers n (%) 11 (19) 11 (19)
Inclusion criteria n (%)   
Arterial reconstruction 27 (47) 30 (51)
Foot ulcer 16 (28) 12 (20)
ABI < 0.8 14 (25) 17 (29)
  1. Group A, diabetic patients treated by endocrinology service. Group B, diabetic patients treated by coordinated team, Family Physicians (FP) and endocrinologist, at primary care site.
  2. Data expressed as median (Q1–Q3) or n (%).
  3. ABI, ankle-brachial index. ACE, angiotensin convert enzyme ARA II, angiotensin II-receptor antagonist.